MAG Optics is a clinical stage ophthalmic device company, developing the first patient-centric corneal shape-changing platform to eliminate the need for contacts/glasses. The intra-corneal implant is used to treat Keratoconus,a progressive,degenerative eye disease that can lead to severe visual impairment. The tech also treats Presbyopia (age-related loss of near vision) and Astigmatism. We've conducted human studies (OUS) and implanted into 21+ patients, with 2Y follow-up data demonstrating remarkable efficacy. We are a resident company at JLabs at UMass-M2D2.